Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent BioPharma, a cutting-edge drug discovery firm, has announced the dispatch of documents for its Annual General Meeting scheduled for November 28, 2024, in Western Australia. Known for its innovative approach in biopharmaceuticals, the company focuses on nanotechnology and multi-target therapies for diseases related to the central nervous system and immunology.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.